Antisickling Effect of Ficus vallis-choudae: A Potential Inhibitor of ErythrocyteMorphological Alterations in Sickle Cell Disease

Authors

  • Mbaye SENE Université Cheikh Anta Diop, BP 5005, Dakar, Sénégal.
  • Ibrahima Diouf Unit of Training and Research in Health Sciences, Assane Seck University of Ziguinchor, Senegal
  • Awa BA Faculty of Health and Sustainable Development, Alioune Diop University, Bambey, Senegal
  • Diop Doudou Laboratory of Botany, Basic Instute of Black Africa, University Cheikh Anta Diop of Dakar, Dakar, Senegal,
  • Niasse Rokhy Laboratoire de Physiologie Pharmaceutique, FMPO, Cheikh Anta Diop University, Dakar, Senegal
  • Ba Fatoumata UFR Santé, Université Gaston Berger, Saint-Louis, Sénégal
  • Diaw Ndeye Absatou Laboratoire de Physiologie Pharmaceutique, FMPO, Cheikh Anta Diop University, Dakar, Senegal
  • Kane Modou Oumy Laboratoire de Physiologie Pharmaceutique, FMPO, Cheikh Anta Diop University, Dakar, Senegal
  • Sarr Mamadou Laboratoire de Physiologie Pharmaceutique, FMPO, Cheikh Anta Diop University, Dakar, Senegal

DOI:

https://doi.org/10.37506/q4zmt370

Keywords:

Sickle cell disease, Antisickling, Ficus vallis-choudae

Abstract

Background: The aim of this study is to evaluate whether a hydroethanolic extract of Ficus vallis-choudae (EFFV) leaves can
prevent the sickling of red blood cells in individuals with sickle cell carriers(AS) and homozygous sickle cells (SS).
Material and Methods: Ten grammes of Ficus vallis-choudae leaf powder were macerated in 100 ml of a 60% hydroethanolic
solution. After filtration, the macerate was subjected to rotary evaporation until a dry crude extract was obtained. This dry
extract was reconstituted in water to prepare two solutions with concentrations of 5 mg/ml and 2.5 mg/ml. Emmel tests
were performed following incubation of the extract solutions with blood from individuals with the AS sickle cell trait,
SS homozygous sickle cell disease, and normal AA controls. The percentage of sickled cells was determined using optical
microscopy.

Results: The hydroethanolic extract of Ficus vallis-choudae (EFFV) significantly reduces sickle cell formation in both AS and
SS individuals. This antisickling effect is dose-dependent.

Conclusion: Our results demonstrate that the hydroethanolic crude extract of Ficus vallis-choudae (EFFV) could have
beneficial effects in the context of sickle cell disease. These findings offer promising prospects for the development of
cost-effective treatments for this condition.

Author Biographies

  • Mbaye SENE, Université Cheikh Anta Diop, BP 5005, Dakar, Sénégal.

    Laboratoire de Physiologie Pharmaceutique, Faculté de Médecine, de Pharmacie et d’Odontologie, Université Cheikh Anta Diop, BP 5005, Dakar, Sénégal.

  • Ibrahima Diouf, Unit of Training and Research in Health Sciences, Assane Seck University of Ziguinchor, Senegal

    Unit of Training and Research in Health Sciences, Assane Seck University of Ziguinchor, Senegal

  • Awa BA, Faculty of Health and Sustainable Development, Alioune Diop University, Bambey, Senegal

    Faculty of Health and Sustainable Development, Alioune Diop University, Bambey, Senegal

  • Diop Doudou, Laboratory of Botany, Basic Instute of Black Africa, University Cheikh Anta Diop of Dakar, Dakar, Senegal,

    Laboratory of Botany, Basic Instute of Black Africa, University Cheikh Anta Diop of Dakar, Dakar, Senegal

  • Niasse Rokhy, Laboratoire de Physiologie Pharmaceutique, FMPO, Cheikh Anta Diop University, Dakar, Senegal

    Laboratoire de Physiologie Pharmaceutique, FMPO, Cheikh Anta Diop University, Dakar, Senegal

  • Ba Fatoumata, UFR Santé, Université Gaston Berger, Saint-Louis, Sénégal

    UFR Santé, Université Gaston Berger, Saint-Louis, Sénégal

  • Diaw Ndeye Absatou, Laboratoire de Physiologie Pharmaceutique, FMPO, Cheikh Anta Diop University, Dakar, Senegal

    Laboratoire de Physiologie Pharmaceutique, FMPO, Cheikh Anta Diop University, Dakar, Senegal

  • Kane Modou Oumy, Laboratoire de Physiologie Pharmaceutique, FMPO, Cheikh Anta Diop University, Dakar, Senegal

    Laboratoire de Physiologie Pharmaceutique, FMPO, Cheikh Anta Diop University, Dakar, Senegal

  • Sarr Mamadou, Laboratoire de Physiologie Pharmaceutique, FMPO, Cheikh Anta Diop University, Dakar, Senegal

    Laboratoire de Physiologie Pharmaceutique, FMPO, Cheikh Anta Diop University, Dakar, Senegal

References

1. Diagne I, et al. Guide de prise en charge: La drépanocytoseen

Afrique. Monaco: Gouvernement de la principauté de

Monaco; 2018. p. 1–82.

2. Weatherall DJ. Phenotype-genotype relationships in

monogenic disease: lessons from the thalassaemias.

Nat Rev Genet. 2001;2:245–55.

3. Alboury B. La drépanocytose au Sénégal:

conséquencessociales [Doctoral thesis]. Montpellier:

Université de Montpellier; 1976.

4. Sane T. Lutte contre la drépanocytose: une association

pour réduire le taux de prévalenceen milieu scolaire

[Internet]. [cited 2025 Jun 4]. Available from: http://

www.lesoleil.sn/article.php3?id_article=48139

5. Diagne I, Tchamogo CJ, et al. Dépistagenéonatal de la

drépanocytose au Sénégal: Étude préliminaire dans

deux maternités de Dakar. XVIèmesJournéesMédicales,

Pharmaceutiques, Odontologiques et Vétérinaires; 2006

Feb 6–9; Dakar. Poster No.: C45.

6. Sibinga EMS, et al. Patients with sickle cell disease:

use of complementary and alternative therapies.

J Altern Complement Med. 2006;12:291–8.

7. Wambebe C, et al. Double-blind, placebo-controlled,

randomized cross-over clinical trial of NIPRISAN

in patients with sickle cell disorder. Phytomedicine.

2001;8(4):252–61.

8. Bankeu JJ, et al. Characterization of bioactive

compounds from Ficus vallis-choudae Delile (Moraceae).

Trends Phytochem Res. 2017;1(4):235–42.

9. Lawan A, et al. Effet anti-inflammatoires et antinociceptifs

de l’extraitméthanolique de l’écorce de tige

de Ficus vallis-choudae Delile (Moraceae). J Afr Pharm

Pharmacol. 2008 Dec;2(10):200–3. Available from:

http://www.academicjournals.org/ajpp

10. Labie D, Wajcman H, et al. Biologie de l’hémoglobine

S: Épidémiologie et génétique, physiopathologie,

biologieclinique, diagnostic anténatal. In: La

MaladieDrépanocytaire. Paris: Editions Sandoz; 1984.

p. 14–63.

11. Démélé M. Étude des plantes médicinalesusitées dans

la prise en charge de la drépanocytose à Bamako (Mali).

Bamako: 2018. 104 p.

12. Nongonierma BR, et al. Action antidrépanocytaire

de l’extraitacétonique des écorces de tige du Ficus

gnaphalocarpa (MIQ) STEND/J. Soc Ouest-Afr Chim.

2007;(024):95–101.

13. Kane MO, Sene M, Diaw M, Seck M, Ba A, Ba F, et

al. Effets d’un extrait de Hibiscus sabdariffa sur la

viscosité sanguine et la falciformationérythrocytaire

chez des sujetsdrépanocytaires. J Sci Pharm Biol.

2013;14(2):34–41.

14. Diouf M, Sene M, Doudou D, Diaw A, Toure M, Diagne

M, et al. Study of the antidrepanocytary properties

of an extract of Ficus umbellata leaves. Natl J Physiol

Pharm Pharmacol. 2020;10(6):504–7. doi:10.5455/njppp.

2020.10.02054202029042020

15. Diouf M, Sene M, Ba A, Ndiaye M, Sene M, Ouedraogo

A, et al. Antisickling properties of hydro-alcoholic

extract of Ficus abutilifolia leaves. J Afr Assoc Physiol Sci.

2024;12(2):31–7. doi:10.4314/jaaps.v12i2.4

16. Mpiana PT. Antisickling activity of anthocyanins

from Bombax pentadrum, Ficus capensis, and Ziziphus

mucronata: photodegradation effect. J Ethnopharmacol.

2008;120:413–8.

17. Elion J, Labie D. Génétique de la drépanocytose. In:

La drépanocytose. Paris: John Libbey Eurotext; 2003.

p. 1–10.

18. Abutu L, Scott C. Un nouveau traitement antidrépanocytose

prêt pour les essaiscliniques. Editions

Afrique Sub-Saharienne; 2009 May 22 [cited 2025 Jun

4]. Available from: http://www.scidev.net

19. Bankeu JJ, et al. Tendances à la recherche

phytochimique. Trends Phytochem Res. 2017;1(4):

235–42.

Downloads

Published

2025-10-27

How to Cite

Antisickling Effect of Ficus vallis-choudae: A Potential Inhibitor of ErythrocyteMorphological Alterations in Sickle Cell Disease. (2025). International Journal of Physiology, 13(2), 1-6. https://doi.org/10.37506/q4zmt370

Most read articles by the same author(s)